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Purpose: To evaluate malignancy risk according to ultrasound (US) features and 
size change on follow-up US in mixed echoic thyroid nodules and to suggest man-
agement guidelines thereof. Materials and Methods: Among patients who under-
went US-guided fine needle aspiration biopsy, 316 mixed echoic nodules in 303 
patients were included after excluding the patients with pure solid or cystic nod-
ules or without further cytopathologic evaluation. We evaluated malignancy risk 
according to US features and changes in size and shape on follow-up US. Results: 
The malignancy rate was 31.6% (6 of 19) for nodules with suspicious US features 
and 2.7% (8 of 297) for nodules without suspicious US features (p<0.001). 
Among 265 nodules with no suspicious US features and initial benign cytology, 
15 nodules with suspicious US change and decreased size, 25 nodules with no sus-
picious US change and increased size, and 225 nodules with no suspicious US 
change and no change in size were observed on follow-up USs. The malignancy 
risk thereof was 0%, 0% and 0.4%, respectively (p=1.000). Conclusion: Mixed 
echoic nodules with no suspicious US features and benign cytology can be fol-
lowed up using US, as they revealed very low malignancy rates, even if they 
showed growth on follow-up US.
Key Words:   Mixed echoic thyroid nodules, fine needle aspiration biopsy, ultra-
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INTRODUCTION
Many thyroid nodules are incidentally detected in daily clinical practice, and they 
are present in nearly 50% of adults, increasing in prevalence with age;1 however, 
less than 5% of those nodules are malignant.2 Cystic thyroid nodules represent 15-
53.8% of all surgically excised thyroid nodules,3-7 including true or simple thyroid 
cysts, with an epithelial lining, and mixed nodules with a predominantly fluid 
component.2,6 Among them, cystic thyroid nodules which are thyroid nodules 
characterized by the presence of both solid and cystic components and are referred 
to as “mixed echoic thyroid nodules”,8 have been regarded as benign lesions that 
can be managed conservatively in the past.9,10 However, the percentage of malig-
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cords. However, informed consent for US-FNAB was ob-
tained from all patients before conducting the procedure. 
From March 2006 to February 2007, 953 thyroid nodules in 
868 consecutive patients underwent US-FNAB at our institu-
tion (a referral center) in Seoul, Korea. Among them, 580 
nodules were excluded because they were either pure solid 
(n=576) or cystic nodules (n=4). Patients who met the fol-
lowing criteria upon review of their medical records, includ-
ing cytologic and histopathologic results, were included in 
this study: 1) underwent thyroid surgery, 2) at least two be-
nign cytologic results, and 3) benign results on initial cyto-
logic results with no interval change or decrease in size at 
follow-up US after at least 12 months. Forty nodules were 
excluded owing to increase in size on follow-up US without 
further cytopathologic evaluation after demonstrating benign 
results on initial cytology. Seventeen nodules were also ex-
cluded because of lack of subsequent surgery after either 
papillary thyroid carcinoma (PTC) (n=2), suspicion of PTC 
(n=1), and indeterminate (n=1) or lack of subsequent surgery 
or follow-up FNAB after demonstrating inadequate results 
(n=13) on initial cytology. In total, this study included 316 
mixed echoic nodules in 303 patients (Fig. 1). The mean age 
of the patients as a whole was 49.1 years (range, 16-80 
years); the mean age of the male patients was 51.6 years 
(range, 21-72 years), and the mean age of the female patients 
was 49 years (range, 16-80 years). The mean size of the thy-
roid nodules was 20 mm (range, 4-76 mm).  
nancy among these mixed echoic nodules has been report-
ed from 2% to 18%,2,4,6-8,11 however, these nodules often 
show non-diagnostic or inadequate cytologic result due to 
scant or no follicular cells, owing to the cystic portion,2,12 
which is a challenge in managing these nodules with fine 
needle aspiration biopsy (FNAB).13 
Repeated FNAB or surgery is advised for nodules that in-
crease in size during follow-up.14-18 However, these mixed 
echoic nodules can increase in size upon follow-up ultra-
sound (US) by cystic degeneration,3,4 or sometimes they are 
decreased in size and demonstrate newly suspicious US fea-
tures after FNAB by reduction of cystic portion.19 Until 
now, the management of mixed echoic thyroid nodules has 
not been firmly established, nor has a concrete study thereon 
been reported, to the best of our knowledge. The aim of this 
study was to evaluate the risk of malignancy, according to 
initial US features, US changes, or changes in size on fol-
low-up US, in mixed echoic nodules and to suggest guide-
lines for managing these nodules. 
MATERIALS AND METHODS
　　　
Study population
Our institutional review board approved this retrospective 
observational study, and required neither patient approval, 
nor informed consent for review of patient images and re-
Fig. 1. Diagram of the study population. non-op, without operation; Op, with operation; FNA, fine needle aspiration.
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ule. Also, we defined newly developed suspicious US fea-
tures as a transition from being probably benign on initial US 
to suspiciously malignant on follow-up US after FNAB. 
       
Cytologic evaluation 
FNAB was performed by a single radiologist after US evalu-
ations of thyroid glands for either thyroid nodules with suspi-
cious US features or the largest nodule present if no suspi-
cious malignant US features were detected. FNAB was 
conducted with the patient in the supine position with the 
neck extended using a 23-gauge needle (Korea Vaccine, 
Seoul, Korea) attached to a 20 mL disposable plastic syringe 
(Kovax-Syringe, Korea Vaccine) and an aspirator under US 
guidance with a free hand technique. Each lesion was aspi-
rated at least twice. All cystic fluid was aspirated as much as 
possible from the cystic portion of the nodules and then 
FNAB was performed on the solid portion of the nodules. If 
complete aspiration was not possible in the thick cystic con-
tents of thyroid nodules, FNAB was directly conducted on 
the solid portion of the mixed echoic nodules. Materials ob-
tained from FNAB were smeared on glass slides, which were 
immediately placed in 95% alcohol for Papanicolau staining, 
and the remaining material in the syringe was rinsed in saline 
for processing as a cell block. A cytologist was not on site 
during the biopsy. Cytology samples were sent to the pathol-
ogy department and the results were reported by 1 of 5 cyto-
pathologists in an official report form. Additional special 
staining was performed on a case-by-case basis following the 
discretion of the cytopathologist. Cytological results were 
classified as into one of the following two categories: “ade-
quate” or “inadequate” for interpretation. A specimen was 
considered as “adequate” if there was a minimum of six 
groupings of well-preserved thyroid cells consisting of at 
least ten cells per group.23 The “adequate” group was divided 
into four subgroups: “benign”, “indeterminate”, “suspicious 
for PTC”, and “PTC”. “Benign” cytology included colloid 
nodules, nodular hyperplasia, lymphocytic thyroiditis, Graves’ 
disease, and postpartum thyroiditis. “Indeterminate” cytology 
included follicular and Hürthle cell neoplasm. “Suspicious for 
PTC” cytologic results were defined when the specimen ex-
hibited cytological atypia, but showed insufficient cellularity 
for definite diagnosis of PTC. Cytologic results were desig-
nated as “PTC” when specimen revealed abundant cells with 
definite cytological features of malignancy.24 
Reference standards 
Malignant nodules were confirmed by surgery or FNAB, 
Imaging and image analysis
US was performed with an 8- to 15-MHz linear array trans-
ducer (Acuson Sequoia; Siemens Medical Solutions, Moun-
tain View, CA, USA), a 7- to 15-MHz linear array transducer 
(HDI 5000; Philips Medical Systems, Bothell, WA, USA), or 
a 5- to 12-MHz linear array transducer (iU22; Philips Medi-
cal Systems). Compound imaging was obtained in all images 
with HDI 5000 or iU22 machines. Real-time US imaging 
was performed by one of three radiologists with 11, 9, and 7 
years of experiences in thyroid imaging who were aware of 
the patients’ clinical background. US images were indepen-
dently reviewed by each of two radiologists dedicated to thy-
roid imaging (K.J.Y. and S.Y.M. with 9 and 3 years of expe-
rience). Each thyroid nodule was described according to US 
features as devised in a previous report.20 We defined the cys-
tic nodules, as designated in previous studies,2-6,13,21,22 as 
mixed echoic nodules comprising solid and cystic compo-
nents.8 These mixed echoic nodules were evaluated based on 
their internal solid components. Echogenicity of the solid 
portion was categorized as hyperechoic (for nodules showing 
hyperechogenicity compared to the normal thyroid), isoecho-
ic (for nodules showing isoechogenicity compared to the 
normal thyroid), hypoechoic (for nodules showing hy-
poechogenicity compared to the normal thyroid), or marked-
ly hypoechoic (for nodules showing hypoechogenicity com-
pared to the adjacent strap muscle). Margins of the nodules 
were classified as either well-circumscribed, microlobulated, 
or irregular. The degree of calcification was categorized as 
microcalcification (punctate echogenic foci of 1 mm or less), 
macrocalcification (punctate echogenic foci larger than 1 mm 
in size or eggshell calcification), mixed calcification (micro-
calcification combined with eggshell or macrocalcification) 
or negative (no calcification). Nodule shape was categorized 
as wider than tall or taller than wide. US groupings of thyroid 
nodules were classified as probably benign or suspiciously 
malignant in these nodules, using the sonographic criteria 
suggested by Kim, et al.20 Malignant sonographic character-
istics were defined as microcalcification, irregular or microl-
obulated margins, markedly hypoechogenicity, and taller 
than wide shape. A suspiciously malignant nodule was de-
fined as a nodule showing one or more of the suspicious 
findings presented above. If a nodule showed no suspicious 
features, it was classified as probably benign. We evaluated 
the changes in size and shape of the thyroid nodules on fol-
low-up US in this study. We categorized nodules as being in-
creased in size when its maximum diameter increased by 
more than 3 mm,21 irrespective of the initial size of the nod-
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or patient request (n=71), growth at follow-up US (n=26), 
suspicious US features (n=25) and newly developed suspi-
cious features with decreased size at follow-up US (n=5). 
The mean interval between initial and follow-up FNAB was 
23.3 months (range, 3-51 months). Follow-up US was per-
formed in 152 nodules and the mean interval between initial 
and follow-up US was 30.9 months (range, 10-58 months). 
       
Correlations of risk of malignancy according to US 
features and size change on follow-up US
Of the 316 nodules, there were 19 (6%) nodules with suspi-
cious US features and 297 (94%) nodules with no suspicious 
US features. The rate of malignancy was 31.6% (6 of 19) for 
thyroid nodules with suspicious US features and 2.7% (8 of 
297 nodules) for those with no suspicious US features. There 
was significant difference between US grouping of thyroid 
nodules and the rate of malignancy (p<0.001).
Among thyroid nodules with initially benign cytology 
(n=298), the malignancy rate of thyroid nodules assessed as 
having suspicious US features was 7.7% (1/13) while those 
with no suspicious US features was 1.1% (3/285) (p=0.164). 
Of thyroid nodules (n=275) with initial benign cytology that 
underwent follow-up US or FNAB, there were 26 nodules 
of increased size with a mean size of 5.8 mm (from range 
of 8-76 mm to the range of 12-81 mm), 156 nodules with 
no change in size and 93 nodules with decreased size. There 
were no thyroid nodules observed with suspicious change 
and growth. Of these nodules (n=275) with initial benign 
cytology that underwent follow-up US or FNAB, 265 thy-
roid nodules had no suspicious US features, while 10 had 
suspicious US features. Among the 265 thyroid nodules with 
no suspicious US features and benign results on initial cy-
tology, there were 15 nodules with suspicious US change 
and decreased size (Fig. 2), 25 with no suspicious US change 
and increased size (Fig. 3) and 225 with no suspicious US 
change as well as no change or decrease in size on follow-
up US. The likelihood of a nodule being benign based on 
standard reference was 100% (15 of 15) in the group of nod-
ules with suspicious US change and decreased size, 100% 
(25 of 25) in the group with no change in shape and increased 
size, and 99.6% in the group with no change in shape and 
size or decreased size (224 of 225), respectively. Therefore, 
the risk of malignancy was 0%, 0% and 0.4%, respectively, 
showing no statistical difference among the three groups 
(p=1.000).  
Of six thyroid nodules with inadequate cytology (two con-
firmed by surgery and four by repeat FNAB), there was no 
while benign nodules were confirmed as benign if they were 
classified as benign at both initial and follow-up FNAB, 
upon surgery, or if the nodules either decreased or showed 
no interval change at follow-up US at least 12 months (mean, 
30.7 months; range, 12-58 months) after being classified as 
benign on FNAB. 
Statistical analysis
We used a χ2-test to determine differences between malignant 
and benign nodules according to categorical variables. We 
also evaluated the differences between malignant and benign 
nodules with continuous variables using an independent two 
sample t-test. Statistical significance was assumed when the 
p-value was less than 0.05. All reported p-values were two-
sided. Statistical analyses were performed by using SAS soft-
ware version 9.1 (SAS Institute Inc., Cary, NC, USA).
 
RESULTS
 
Final cytopathologic results
Of the 316 thyroid nodules, 14 (4.4%) were malignant and 
302 (95.6%) were benign. The mean size of the malignant 
nodules were 19.1±13.7 mm, showing no significant differ-
ences to the benign nodules (20.0±12.2 mm) (p=0.773). 
The mean age (49.6±11.7 years) of the patients with benign 
nodules was significantly older than that (40.5±12.5 years, 
p=0.006) of the patients with malignant nodules. There were 
no significant differences between benign and malignant 
nodules according to gender (p=0.337). 
Among total 316 nodules, there were 298 benign results: 
8 suspicious for PTC, 4 PTC and 6 inadequate results ac-
cording to follow-up US or cytopathologic confirmation. 
Thirty-seven nodules (11.7%) underwent surgery without 
undergoing follow-up FNAB or US, for the following rea-
sons: cytologic results suspicious for PTC (n=8) and PTC 
(n=4), large size nodules with inadequate (n=2) or benign 
(n=14) cytology, and upon patient request (n=9). Among 
those who underwent surgery, 13 were malignant and the 
remaining 24 were benign. 
The remaining 279 nodules underwent follow-up FNAB 
or follow-up US after more than 12 months. The mean size 
of the initial thyroid nodules was 19.7±11.7 mm (range, 4-76 
mm) and the mean size of the nodules after follow-up US or 
FNAB was 16.9±11.5 mm (range, 2-81 mm) (p<0.001) in 
these 279 nodules. Follow-up FNAB was performed in 127 
nodules. The grounds for follow-up FNAB were: clinician 
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ular or microlobulated margins,17,20,30,34-38 hypoechogenici-
ty,17,20,29,30,34,37,38 marked hypoechogenicity,20,29 taller than wide 
shape,17,20,39 microcalcification,17,20,30,36-38,40-42 solid composi-
tion17,36-38,43 and intratumoral vascularity.17,30,34,43 US findings 
are also important for the discrimination of mixed echoic 
thyroid nodules. The eccentric location of a solid mural 
nodule,8,17,25,44 eccentric configuration with an acute angle of 
the solid portion,25 its vascularity of the solid portion,40 and 
the presence of microcalcification8,25,44 have been reported 
as suspicious US features in mixed echoic nodules sugges-
tive of PTC. 
We intended to evaluate the risk of malignancy according 
to US features and US change or size change on follow-up 
US in the mixed echoic nodules. The rate of malignancy was 
31.6% for thyroid nodules with suspicious US features, sig-
nificantly higher in comparison to 2.7% nodules with no sus-
picious US features in this study. These results indicate the 
importance of US features in differentiating benign from ma-
malignancy. Five of them showed no suspicious US fea-
tures, and one had suspicious US features. Four nodules 
showed no suspicious US change with decreased size (n=2) 
and no change in size (n=2). The remaining two nodules 
underwent surgery without follow-up.  
DISCUSSION
Mixed echoic nodules represent 15-53.8% of all surgical 
excised thyroid nodules.3-7 They have been regarded as be-
nign nodules with a rare risk of malignancy and can be 
managed conservatively.9,10 However, the incidence of ma-
lignancy in these mixed echoic nodules are reported as 2% 
to 18%.2,4,6-8,11,25 Accordingly, the concrete assessment of the 
management of these nodules is necessary. Discriminating 
between benign and malignant thyroid nodules, many re-
ports17,20,26-33 described suspicious US features such as irreg-
Fig. 2. A 51-year-old woman with a thyroid nodule in the right thyroid on US. Initial FNAB revealed the nodule to be benign on cytology, and follow-up FNAB 
after 1.5 year showed the same cytologic result. (A) Initial US shows a mixed echoic nodule (>50% cystic) (arrows). (B) On follow-up US, this nodule showed 
decreased size and suspicious US changes including hypoechoic and microlobulated margins and taller-than wide shape (arrows). US, ultrasound; FNAB, 
fine needle aspiration biopsy.
Fig. 3. A 56-year-old woman with a thyroid nodule in the right thyroid on US. Initial FNAB revealed the nodule to be benign on cytology, and follow-up FNAB 
after 3 year showed the same cytologic result. (A) Initial US shows a mixed echoic nodule (< 50% cystic) (arrows). (B) On follow-up US, this nodule showed 
increased size without change in shape (arrows). US, ultrasound; FNAB, fine needle aspiration biopsy.
A
A
B
B
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nodule was, the lower the likelihood of cancer with statisti-
cal significance. Lower malignancy rate was also reported 
in thyroid nodules of inadequate cytology without suspi-
cious US features, compared with those with suspicious US 
features, especially, in cystic nodules.46 Of the six thyroid 
nodules with inadequate cytology in this study, five of them 
showed no suspicious US features, and one had suspicious 
US features, and there was no malignant lesion, consistent 
with other report.46 
There are several limitations to our study. First, there was 
relatively small number of patients with mixed echoic nod-
ules among the total study population and only a small 
number of nodules (n=37, 11.7%) was underwent surgery. 
Also, the remaining thyroid nodules which were included 
in this study were underwent follow-up US at least 12 
months or FNAB without surgery as a reference standard. 
A somewhat short follow-up period of 12 months was also 
another limitation, and the possibility of false negative and 
false positive results exists. Second, this study was a retro-
spective one, thus color Doppler images of the sold portion 
of mixed echoic nodules were not evaluated. Also, this 
study contemplated the entire nodule instead of only the 
solid portion as representative of nodular growth. The re-
vised American Thyroid Association guidelines suggested 
that repeat FNAB should be based upon growth of the solid 
component, especially for, mixed echoic nodules;16 the dif-
ferentiation of solid and cystic components in mixed echoic 
nodules is challenging since the solid and cystic compo-
nents are intermingled. Thus, the measurement of growth 
of the solid component only is difficult. To resolve this is-
sue, 3D US might be helpful. Lastly, in this study, because 
there was no combination of thyroid nodules classified as 
benign on cytology that showed both no changes in size or 
growth with benign nodules that showed newly developed 
suspicious changes on follow-up US, the larger study group 
that can fulfill these combinations will be necessary.  
In conclusion, the management of mixed echoic nodules 
depends on US features. The nodules with no suspicious 
US features and benign cytology can be followed up using 
US, as they revealed very low rate of malignancy, even if 
they showed growth on follow-up US.
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